Fluoro-deoxyglucose positron emission tomography imaging for the detection of occult disease in multiple myeloma

被引：47
|
作者：
Orchard, K
Barrington, S
Buscombe, J
Hilson, A
Prentice, HG
Mehta, A
机构：
[1] UCL Royal Free & Univ Coll Med Sch, Dept Haematol, London, England
[2] Kings & St Thomass Hosp, Clin PET Ctr, London, England
[3] UCL Royal Free & Univ Coll Med Sch, Dept Nucl Med, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2002年 / 117卷 / 01期
关键词：
myeloma; FDG-PET; imaging; occult disease; non-secretory;
D O I：
10.1046/j.1365-2141.2002.03407.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Positron emission tomography with 2-deoxy-2-[18]fluoro-d-glucose (FDG-PET) imaging has been extensively used to detect occult metastatic malignant lesions in patients with carcinoma. We describe its use in three patients with multiple myeloma, each representing a particular clinical situation in which this imaging modality offered advantages over plain radiography, computerized tomography or magnetic resonance imaging. FDG-PET provides a whole body image showing sites of occult disease. This is of particular value in patients with non-secretory myeloma, solitary plasmacytoma or for those that relapse with focal disease following autologous or allogeneic stem cell transplantation.
引用
收藏
页码：133 / 135
页数：3
相关论文
共 50 条
  • [31] Evaluation of efficacy and clinical impact of positron emission tomography with 18f fluoro-deoxyglucose (FDG) in patients with suspicion of recurrent laryngeal carcinoma
    Alvarez Perez, R. M.
    Borrego Dorado, I.
    Vazquez Albertino, R.
    Ruiz Franco-Baux, J.
    Ceballo Pedraja, J. M.
    Esteban Ortega, F.
    ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2006, 57 (03): : 134 - 139
  • [32] Basic principles of 18F-fluoro-deoxyglucose positron emission tomography
    Standke, R
    ACTA MEDICA AUSTRIACA, 2002, 29 (05) : 149 - 155
  • [33] Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis
    Hiroshi Ohira
    Ichizo Tsujino
    Shinji Ishimaru
    Noriko Oyama
    Toshiki Takei
    Eriko Tsukamoto
    Masatake Miura
    Shinji Sakaue
    Nagara Tamaki
    Masaharu Nishimura
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 933 - 941
  • [34] Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis
    Ohira, Hiroshi
    Tsujino, Ichizo
    Ishimaru, Shinji
    Oyama, Noriko
    Takei, Toshiki
    Tsukamoto, Eriko
    Miura, Masatake
    Sakaue, Shinji
    Tamaki, Nagara
    Nishimura, Masaharu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (05) : 933 - 941
  • [35] Role of 18-Fluoro Deoxyglucose Positron Emission Tomography in Children with Leukemia
    Kaya, Zuhre
    Akdemir, Ozgur
    Kocak, Ulker
    Yenicesu, Idil
    Gursel, Turkiz
    BLOOD, 2015, 126 (23)
  • [36] Impact of 18 f-Fluoro-Deoxyglucose Positron Emission Tomography Imaging in the Management of Mantle Cell Lymphoma
    Bouteloup, Juliette
    Kanoun, Salim
    Berriolo-Riedinger, Alina
    Ghesquieres, Herve
    Salles, Gilles A.
    Gargi, Therese
    Mognetti, Thomas
    Nicolas-Virelizier, Emmanuelle
    Belhabri, Amine
    Philippe, Rey
    Voillat, Laurent
    Rossi, Cedric
    Noel, Robin
    Bastie, Jean-Noel M.
    Casasnovas, Olivier
    BLOOD, 2015, 126 (23)
  • [37] Utility of [18F] Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography for Staging and Therapy Response Evaluation in Pediatric Rhabdomyosarcoma: A Case Series and Literature Review
    Sa, Ri
    Liu, Danyan
    Zhao, Hongguang
    Hou, Sen
    Lin, Qiuyu
    Guan, Feng
    FRONTIERS IN MEDICINE, 2020, 7
  • [38] Early Detection of Cardiac Sarcoid Lesions with 18F-fluoro-2-deoxyglucose Positron Emission Tomography
    Ohira, Hiroshi
    Tsujino, Ichizo
    Sato, Takahiro
    Yoshinaga, Keiichiro
    Manabe, Osamu
    Oyama, Noriko
    Nishimura, Masaharu
    INTERNAL MEDICINE, 2011, 50 (11) : 1207 - 1209
  • [39] Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas
    Karam, Maroun
    Novak, Leon
    Cyriac, Jomol
    Ali, Ameera
    Nazeer, Tipu
    Nugent, Francis
    CANCER, 2006, 107 (01) : 175 - 183
  • [40] Serial whole body fluoro-deoxyglucose (FDG) imaging for non-secretory myeloma and recurrent plasmacytomata.
    Durie, BGM
    Waxman, AD
    D'Agnolo, A
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 119P - 119P
12345